These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28434305)

  • 21. Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis.
    Mahfouz M; Maruyama R; Yokota T
    Methods Mol Biol; 2020; 2176():87-98. PubMed ID: 32865784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
    Benson MD; Waddington-Cruz M; Berk JL; Polydefkis M; Dyck PJ; Wang AK; Planté-Bordeneuve V; Barroso FA; Merlini G; Obici L; Scheinberg M; Brannagan TH; Litchy WJ; Whelan C; Drachman BM; Adams D; Heitner SB; Conceição I; Schmidt HH; Vita G; Campistol JM; Gamez J; Gorevic PD; Gane E; Shah AM; Solomon SD; Monia BP; Hughes SG; Kwoh TJ; McEvoy BW; Jung SW; Baker BF; Ackermann EJ; Gertz MA; Coelho T
    N Engl J Med; 2018 Jul; 379(1):22-31. PubMed ID: 29972757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transthyretin amyloidoses: advances in therapy.
    Dubrey S; Ackermann E; Gillmore J
    Postgrad Med J; 2015 Aug; 91(1078):439-48. PubMed ID: 26048914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
    Gonçalves P; Martins H; Costelha S; Maia LF; Saraiva MJ
    Amyloid; 2016 Dec; 23(4):249-253. PubMed ID: 27884058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
    [No Abstract]   [Full Text] [Related]  

  • 26. siRNA therapy improves multimodality imaging in hereditary transthyretin cardiac amyloidosis: a case report.
    Awaya T; Endo J; Iijima R; Shimoda M; Moroi M
    QJM; 2024 Apr; 117(4):304-306. PubMed ID: 38229248
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR
    Benson MD; Ackermann EJ; Monia BP
    Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337
    [No Abstract]   [Full Text] [Related]  

  • 28. Response by Solomon to Letter Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study".
    Solomon SD
    Circulation; 2019 Jul; 140(2):e92-e93. PubMed ID: 31283371
    [No Abstract]   [Full Text] [Related]  

  • 29. From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis.
    Russo M; Gentile L; Toscano A; Vita G; Mazzeo A
    Amyloid; 2020 Dec; 27(4):279-280. PubMed ID: 32515606
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis.
    Suhr OB; Holmgren G; Lundgren E
    Liver Transpl; 2004 Dec; 10(12):1551-3. PubMed ID: 15558840
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
    Coelho T; Adams D; Silva A; Lozeron P; Hawkins PN; Mant T; Perez J; Chiesa J; Warrington S; Tranter E; Munisamy M; Falzone R; Harrop J; Cehelsky J; Bettencourt BR; Geissler M; Butler JS; Sehgal A; Meyers RE; Chen Q; Borland T; Hutabarat RM; Clausen VA; Alvarez R; Fitzgerald K; Gamba-Vitalo C; Nochur SV; Vaishnaw AK; Sah DW; Gollob JA; Suhr OB
    N Engl J Med; 2013 Aug; 369(9):819-29. PubMed ID: 23984729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study".
    González-Costello J; Casasnovas C; Díez-López C
    Circulation; 2019 Jul; 140(2):e90-e91. PubMed ID: 31283374
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective silencing of a mutant transthyretin allele by small interfering RNAs.
    Kurosawa T; Igarashi S; Nishizawa M; Onodera O
    Biochem Biophys Res Commun; 2005 Nov; 337(3):1012-8. PubMed ID: 16225852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress in the understanding and treatment of transthyretin amyloidosis.
    Sekijima Y
    J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
    Cisneros-Barroso E; Losada-López I; González-Moreno J; Buades J; Ferrer-Nadal A; Ripoll-Vera T; Usón M; Figuerola A; Montalà JC; Descals C; Salva-Ramonell F; Torres-Rovira J; Gene-Heym A; Fernández-Burgos I; Soler T
    Amyloid; 2019; 26(sup1):59-60. PubMed ID: 31343326
    [No Abstract]   [Full Text] [Related]  

  • 36. Orphan amyloid diseases.
    Nat Struct Biol; 2000 Apr; 7(4):259-60. PubMed ID: 10742161
    [No Abstract]   [Full Text] [Related]  

  • 37. Guideline of transthyretin-related hereditary amyloidosis for clinicians.
    Ando Y; Coelho T; Berk JL; Cruz MW; Ericzon BG; Ikeda S; Lewis WD; Obici L; Planté-Bordeneuve V; Rapezzi C; Said G; Salvi F
    Orphanet J Rare Dis; 2013 Feb; 8():31. PubMed ID: 23425518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline-tauroursodeoxycholic acid treatment: effects in the heart of a transthyretin V30M transgenic mouse model.
    Teixeira C; Costelha S; Martins HS; Teixeira A; Saraiva MJ
    Amyloid; 2017 Mar; 24(sup1):80. PubMed ID: 28434372
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis.
    Lau KHV; Prokaeva T; Zheng L; Doros G; Kaku MC; Spencer B; Berk J; Sanchorawala V
    Amyloid; 2024 Jun; 31(2):150-152. PubMed ID: 38073425
    [No Abstract]   [Full Text] [Related]  

  • 40. [An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation].
    Uehara T; Kakuda K; Sumi-Akamaru H; Yamauchi A; Mochizuki H; Naka T
    Rinsho Shinkeigaku; 2016 Nov; 56(11):777-780. PubMed ID: 27784877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.